REGENXBIO (RGNX) Plans $100 Million Stock Offering Amid Market Dip
Related Stocks: RGNX
Read the full article13h ago
You might also wanna read
Biotech NRx to sell new shares to fund growth and operations
#NRXP NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
stocktitan.net·1mo ago
STAT+: Pharmalittle: We’re reading about a Novartis acquisition, Republicans backing clinical trial diversity, and more
Novartis is pushing deeper into antibody-drug conjugate development, paying $1.1 billion upfront to buy Myricx Bio
STAT·10d ago
SpaceX Stock Is Down 35% From Its High Just 1 Day After Joining the Nasdaq-100. Is the Dip a Buy?
A spot in the index was supposed to be the catalyst. So why are shares back near their post-IPO low?
Bars·8d ago
Chip stocks boost global markets ahead of SK Hynix blockbuster US debut
European shares were muted on Friday, with the pan-European STOXX 600 up 0.1%, remaining on track for a weekly loss that could snap a four-
Zawya·7d ago
NextCure (NASDAQ: NXTC) plans reverse merger; Avere holders to own about 98%
NextCure will seek stockholder approval to issue merger and financing shares, effect a reverse stock split if needed, increase authorized co
stocktitan.net·2d ago
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Tenaya Therapeutics Inc. (NASDAQ: TNYA), a clinical-stage biotechnology compa
Manila Times·2d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.